MORROW GEORGE J
Reporting owner on Forms 3, 4 and 5, CIK 1068754.
MORROW GEORGE J reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-03.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| NBIX · NEUROCRINE BIOSCIENCES INCCIK 914475 | director | 1 | 2026-11-03 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| NBIX · NEUROCRINE BIOSCIENCES INCCommon Stock | 2026-11-03 | M exercised | +7,200 | $53.64 | 17,586 | Form 4 |
| NBIX · NEUROCRINE BIOSCIENCES INCCommon Stock | 2026-11-03 | S sold | -100 | $158.18 | 17,486 | Form 4 |
| NBIX · NEUROCRINE BIOSCIENCES INCCommon Stock | 2026-11-03 | S sold | -100 | $162.05 | 17,386 | Form 4 |
| NBIX · NEUROCRINE BIOSCIENCES INCCommon Stock | 2026-11-03 | S sold | -600 | $163.7083 | 16,786 | Form 4 |
| NBIX · NEUROCRINE BIOSCIENCES INCCommon Stock | 2026-11-03 | S sold | -1,226 | $164.7402 | 15,560 | Form 4 |
| NBIX · NEUROCRINE BIOSCIENCES INCCommon Stock | 2026-11-03 | S sold | -908 | $165.706 | 14,652 | Form 4 |
| NBIX · NEUROCRINE BIOSCIENCES INCCommon Stock | 2026-11-03 | S sold | -1,466 | $166.7748 | 13,186 | Form 4 |
| NBIX · NEUROCRINE BIOSCIENCES INCCommon Stock | 2026-11-03 | S sold | -1,500 | $167.7248 | 11,686 | Form 4 |
| NBIX · NEUROCRINE BIOSCIENCES INCCommon Stock | 2026-11-03 | S sold | -1,300 | $168.5325 | 10,386 | Form 4 |
| NBIX · NEUROCRINE BIOSCIENCES INCNon-Qualified Stock Option, derivative | 2026-11-03 | M exercised | -7,200 | $0 | 0 | Form 4 |
| NBIX · NEUROCRINE BIOSCIENCES INCCommon Stock | 2026-11-02 | M exercised | +7,500 | $53.64 | 17,886 | Form 4 |
| NBIX · NEUROCRINE BIOSCIENCES INCCommon Stock | 2026-11-02 | S sold | -1,900 | $144.9751 | 15,986 | Form 4 |
| NBIX · NEUROCRINE BIOSCIENCES INCCommon Stock | 2026-11-02 | S sold | -4,300 | $145.8591 | 11,686 | Form 4 |
| NBIX · NEUROCRINE BIOSCIENCES INCCommon Stock | 2026-11-02 | S sold | -1,300 | $146.7562 | 10,386 | Form 4 |
| NBIX · NEUROCRINE BIOSCIENCES INCNon-Qualified Stock Option, derivative | 2026-11-02 | M exercised | -7,500 | $0 | 7,200 | Form 4 |
| NBIX · NEUROCRINE BIOSCIENCES INCCommon Stock | 2026-10-30 | M exercised | +300 | $53.64 | 10,686 | Form 4 |
| NBIX · NEUROCRINE BIOSCIENCES INCCommon Stock | 2026-10-30 | S sold | -300 | $149 | 10,386 | Form 4 |
| NBIX · NEUROCRINE BIOSCIENCES INCNon-Qualified Stock Option, derivative | 2026-10-30 | M exercised | -300 | $0 | 14,700 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001068754-26-000009 | NEUROCRINE BIOSCIENCES INC | 2026-11-03 |